CTSO insider transaction filings
Cytosorbents Corp — 16 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-16. Screen CTSO transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | MARIANI PETER J — Chief Financial Officer | Purchase (P): 100,000 @ $0.44 | EDGAR |
| 2026-06-15 | 4 | Chan Phillip P. — Chief Executive Officer, Director | Purchase (P): 251,136 @ $0.40 · Purchase (P): 10,333 @ $0.43 | EDGAR |
| 2025-11-20 | 4 | Chan Phillip P. — Chief Executive Officer, Director | Grant/award (A): 100,000 @ $0.64 | EDGAR |
| 2025-08-08 | 4 | Chan Phillip P. — Chief Executive Officer, Director | Grant/award (A): 105,600 @ $0 · Grant/award (A): 136,400 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Jones Edward Raymond — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | BATOR MICHAEL G. — Director | Grant/award (A): 44,000 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | MARIANI PETER J — Chief Financial Officer | Grant/award (A): 71,500 @ $0 · Grant/award (A): 90,000 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Kim Jiny — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Capponi Vincent — President and COO | Grant/award (A): 89,100 @ $0 · Grant/award (A): 111,100 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Deliargyris Efthymios — Chief Medical Officer | Grant/award (A): 70,000 @ $0 · Grant/award (A): 95,000 (derivative) @ $0 | EDGAR |
| 2025-08-08 | 4 | Sobel Alan D. — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2025-03-04 | 4 | BATOR MICHAEL G. — Director | Code (O): 10,000 @ $1.13 · Code (O): 15,879 (derivative) @ $1.13 | EDGAR |
| 2025-02-26 | 4 | Capponi Vincent — President and COO | Code (O): 12,000 @ $1.13 · Code (O): 12,000 (derivative) @ $1.13 | EDGAR |
| 2025-02-26 | 4 | MARIANI PETER J — Chief Financial Officer | Code (O): 32,625 @ $1.13 · Code (O): 32,625 (derivative) @ $1.13 | EDGAR |
| 2025-02-26 | 4 | Chan Phillip P. — Chief Executive Officer, Director | Code (O): 34,168 @ $1.13 · Code (O): 34,168 (derivative) @ $1.13 | EDGAR |
| 2025-02-26 | 4 | Sobel Alan D. — Director | Code (O): 21,950 @ $1.13 · Code (O): 21,950 (derivative) @ $1.13 | EDGAR |
Recent 8-K events — Cytosorbents Corp
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-14 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-08-07 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-06 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-06 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-06-25 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-02 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-03-25 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-11-13 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-10-03 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=CTSO returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →